Semantic Annotation Sample Clauses

A Semantic Annotation clause defines the process and requirements for attaching metadata or descriptive tags to specific terms, data, or sections within a document. In practice, this clause may specify the standards, formats, or ontologies to be used for annotation, and outline responsibilities for ensuring that annotations are accurate and consistently applied. Its core function is to enhance the clarity and interoperability of information by making the meaning of terms explicit, thereby reducing ambiguity and facilitating automated processing or integration with other systems.
Semantic Annotation. The Semantic Annotation service will be a generic cross-disciplinary solution for improving data sets by establishing references to recognized knowledge sources. The main goal of the Semantic Annotation Task Force is to provide a service to generate automatic or manually annotations for data and metadata with semantic concepts/terms. Another important goal is to provide a way to discover the data using the semantic information. This service is required for the communities as a way to:  Answer common problems of general data infrastructures and several communities involved in EUDAT,  Make the uploading of metadata or actual data sets into a general data infrastructure more attractive,  Stimulate data managers/experts to work on annotation and the improvement of controlled vocabularies,  Develop generic tools that communities can adapt to their needs (e.g. different controlled vocabularies, etc.) Currently there are 2 phases defined: 59 ▇▇▇▇://▇▇.▇▇▇▇▇▇.▇▇/information_society/newsroom/cf/itemlongdetail.cfm?item_id=6204 Phase 1 proof of concept and implement all generic functionalities  Annotation of data and metadata  basic analysis of structured data (only for text files) ‒ Extraction of important terms ‒ Matching concepts with a basic knowledge source  Integration of the solution and the User Interface in the EUDAT web site (DRUPAL) Phase 2 extend functionalities and implement the specific Lifewatch use case  extend knowledge source to others than SKOS/RDF  porting the generic DRUPAL solution to DEIMS  Adapt the proof of concepts to other use cases (CLARIN, EPOS, …)  create connectors for the annotation module to other platforms (Invenio, ...) The diagram (Figure 34) below shows an architectural diagram of the LifeWatch use case. AAA Authentication, Authorisation and Accounting AAI Authentication and Authorization Infrastructure ADMIRE ADMIRE (Advanced Data Mining and Integration Research for Europe) is a project co-funded by EU within the FP7 APA Alliance for Permanent Access APARSEN APARSEN (Alliance for Permanent Access to the Records of Science in Europe Network) is a project co-funded by EU within the FP7 API Application programming interface ARC Advanced Resource Connector Aurora Borealis An ESFRI project in the Environmental Sciences domain. BBMRI Biobanking and Biomolecular Resources Research Infrastructure. An ESFRI project in the Biological and Medical Sciences domain. BMS Biological and medical sciences ▇▇▇▇▇▇ ▇▇▇▇▇▇ (Cultural, Artist...
Semantic Annotation. As we said before, from a semantic point of view Cast3LB is an "all words" corpus, in which all nouns, verbs and adjectives have been annotated with its specific sense (or senses) in the context in which appear. There has been annotated 42291 words: 20461 nouns, 13471 verbs and 8543 adjectives.
Semantic Annotation. The available resources in the network (sensors, data, services, users) can be registered and semantically annotated for publication and easier discovery. To ensure that only valid data is ingested into the SEDS Data Repository additional data validation takes place.
Semantic Annotation. Describing the obtained sensor data stream for interoperability or facilitated search is the core objective of the semantic annotation component, as many information management tools. However, the amount of traffic generated by Smart Cities applications can be voluminous, particularly for real time applications in environments with resource constrained devices, for example sensors with limited bandwidth, memory or power. Therefore, the information model that is being used by the system not only needs to explicitly represent the meaning and relationships of terms in vocabularies but also should be lightweight in order to reduce the traffic and processing time. We use a lightweight information model to represent sensory data, which will be detailed in Section 4.2.

Related to Semantic Annotation

  • Authorized Disclosure The Receiving Party may disclose Confidential Information belonging to the Disclosing Party only to the extent such disclosure is reasonably necessary in the following instances: (a) filing or prosecuting Patents as permitted by this Agreement; (b) prosecuting or defending litigation, including responding to a subpoena in a Third-Party litigation; (c) complying with Applicable Laws or regulations (including regulations promulgated by securities exchanges) or court or administrative orders; (d) to its Sublicensees or prospective Sublicensees, Distributors, Third-Party Partners, subcontractors or prospective subcontractors, payors, consultants, agents, and advisors on a “need-to-know” basis in order for the Receiving Party to exercise its rights or fulfill its obligations under this Agreement, each of whom prior to disclosure must be bound by obligations of confidentiality and restrictions on use of such Confidential Information that are no less restrictive than those set forth in this Article 10; provided, however, that, in each of the above situations, the Receiving Party will remain responsible for any failure by any Third Party who receives Confidential Information pursuant to this Section 10.2 to treat such Confidential Information as required under this Article 10; or (e) to bona fide potential and actual investors, acquirors, merger partners, licensees, and other financial or commercial partners solely for the purpose of evaluating or carrying out an actual or potential investment, acquisition, or collaboration, in each case under written obligations of confidentiality and non-use at least as stringent as those herein. (f) Notwithstanding the foregoing, in the event a Party is required to make a disclosure of the other Party’s Confidential Information pursuant to Sections 10.2(b), (c), or (d), it will, except where impracticable, give at least thirty (30) days’ advance notice to the other Party of such disclosure, reasonably consider the comments of the other Party with respect to limiting such disclosure, and use efforts to secure confidential treatment of such Confidential Information at least as diligent as such Party would use to protect its own confidential information, but in no event less than reasonable efforts. In any event, the Parties agree to take all reasonable action to avoid disclosure of Confidential Information hereunder. Any information disclosed pursuant to Sections 10.2(b), (c), or (d) will remain the Confidential Information of the Disclosing Party and subject to the restrictions set forth in this Agreement, including the foregoing provisions of this Article 10.

  • Data Disclosing an Invention If the Parties exchange Data disclosing an invention for which patent protection is being considered, and the furnishing Party identifies the Data as such when providing it to the Receiving Party, the Receiving Party shall withhold it from public disclosure for a reasonable time (one (1) year unless otherwise agreed or the Data is restricted for a longer period herein).

  • Domain and Designation The Top-­‐Level Domain to which this Agreement applies is .komatsu (the “TLD”). Upon the Effective Date and until the earlier of the expiration of the Term (as defined in Section 4.1) or the termination of this Agreement pursuant to Article 4, ICANN designates Registry Operator as the registry operator for the TLD, subject to the requirements and necessary approvals for delegation of the TLD and entry into the root-­‐zone.

  • Instructional Materials A. The Board recognizes that appropriate texts, library reference facilities, maps and globes, laboratory equipment, audio-visual equipment, art supplies, athletic equipment, current periodicals, standard tests and questionnaires, computers, and similar materials are the tools of the teaching profession. B. Efforts shall be continued to seek and use instructional materials which reflect the contribution and presence of diverse ethnic and cultural groups. C. 1. Selection of instructional materials for each school shall be made by a committee of teachers chosen by the faculty within that school.

  • Authorized Disclosures The Receiving Party may disclose Confidential Information belonging to the Disclosing Party to the extent (and only to the extent) such disclosure is reasonably necessary in the following instances: (i) subject to Section 7.2, by either Party in order to comply with applicable non-patent law (including any securities law or regulation or the rules of a securities exchange) and with judicial process, if in the reasonable opinion of the Receiving Party’s counsel, such disclosure is necessary for such compliance; (ii) by either Party, in connection with prosecuting or defending litigation, making regulatory filings, and filing, prosecuting and enforcing patent applications and patents (including Bayer Patent Rights in accordance with Section 6); (iii) by Aegerion, to its Affiliates, potential and future collaborators (including Sublicensees), permitted acquirers or assignees under Section 10.1, research collaborators, subcontractors, investment bankers, investors, lenders, and their and each of Aegerion and its Affiliates’ respective directors, employees, contractors and agents; and (iv) by Bayer to its Affiliates, permitted acquirers or assignees under Section 10.1, investment bankers, investors, lenders, and their and Bayer and its Affiliates’ respective directors, employees, contractors and agents, provided that (1) with respect to Section 7.1(c)(i) or 7.1(c)(ii), where reasonably possible, the Receiving Party shall notify the Disclosing Party of the Receiving Party’s intent to make any disclosure pursuant thereto sufficiently prior to making such disclosure so as to allow the Disclosing Party adequate time to take whatever action it may deem appropriate to protect the confidentiality of the information to be disclosed, and (2) with respect to Sections 7.1(c)(iii) and 7.1(c)(iv), each of those named people and entities must be bound prior to disclosure by confidentiality and non-use restrictions at least as restrictive LICENSE AGREEMENT as those contained in this Section 7 (other than investment bankers, investors and lenders, who must be bound prior to disclosure by commercially reasonable obligations of confidentiality). In addition to the foregoing, Aegerion and its Affiliates and Sublicensees may make such disclosures of Bayer Know-How specifically concerning the Licensed Compound and its use as any of them may deem reasonably necessary for their business.